Insulin therapy in type 1 diabetes is recommended as multiple dose injections (MDI) or continuous subcutaneous insulin infusion (CSII) to deliver a basal background insulin dose together with bolus insulin doses prior to meals. Use of automated bolus calculators and / or continuous glucose monitors with MDI have been shown to improve glycaemic control in type 1 diabetes patients. Several models of insulin pumps with various features are available. CSII offers greater flexibility with a reduced number of injections but in view of its complexity, patients who will benefit from this therapy need to be carefully selected.peer-reviewe
"In this paper several multi-doses control regimens are suggested for type 1 diabetic patients. The ...
Although the insulin bolus calculator is increasingly being used by people with type 1 diabetes (T1D...
Abstract Aims The aim of this study was to compare individuals with type 1 diabetes with continuous ...
Introduction: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Multiple daily injections (MDI) are an intensive method of administering an external source of basal...
There exist a number of therapeutic options for the management of Type 1 diabetes (T1D). Multiple da...
Achieving optimal glucose control with minimal hypoglycemia and minimizing the impact of diabetes on...
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dos...
The pancreas in a non-diabetic patient constantly secretes a small amount of insulin (basal secretio...
Both Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injections (MDI) are effecti...
Both Continuous Subcutaneous Insulin Infusion (CSI) and Multiple Daily Injections (MDI) are effectiv...
Continuous subcutaneous insulin infusion (CSII), more commonly known asinsulin pump therapy, deliver...
<p class="Continutabstract">The purpose of the current research was to assess changes in daily insul...
Achieving and maintaining glycemic control (glycated hemoglobin – HbA1c≤7.0% according to American D...
"In this paper several multi-doses control regimens are suggested for type 1 diabetic patients. The ...
Although the insulin bolus calculator is increasingly being used by people with type 1 diabetes (T1D...
Abstract Aims The aim of this study was to compare individuals with type 1 diabetes with continuous ...
Introduction: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a tre...
Multiple daily injections (MDI) are an intensive method of administering an external source of basal...
There exist a number of therapeutic options for the management of Type 1 diabetes (T1D). Multiple da...
Achieving optimal glucose control with minimal hypoglycemia and minimizing the impact of diabetes on...
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dos...
The pancreas in a non-diabetic patient constantly secretes a small amount of insulin (basal secretio...
Both Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injections (MDI) are effecti...
Both Continuous Subcutaneous Insulin Infusion (CSI) and Multiple Daily Injections (MDI) are effectiv...
Continuous subcutaneous insulin infusion (CSII), more commonly known asinsulin pump therapy, deliver...
<p class="Continutabstract">The purpose of the current research was to assess changes in daily insul...
Achieving and maintaining glycemic control (glycated hemoglobin – HbA1c≤7.0% according to American D...
"In this paper several multi-doses control regimens are suggested for type 1 diabetic patients. The ...
Although the insulin bolus calculator is increasingly being used by people with type 1 diabetes (T1D...
Abstract Aims The aim of this study was to compare individuals with type 1 diabetes with continuous ...